Scpharmaceuticals Stock Story
SCPH Stock | USD 4.57 0.01 0.22% |
Under 61% of Scpharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Scpharmaceuticals stock suggests that many investors are alarmed at this time. Scpharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Scpharmaceuticals. The current market sentiment, together with Scpharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Scpharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Scpharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Scpharmaceuticals daily returns and investor perception about the current price of Scpharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Scpharmaceuticals |
Requested story not found. it has been either deleted or moved. View all stories for Scpharmaceuticals.
Scpharmaceuticals Latest Timeline
Scpharmaceuticals is listed for 4.57. About 75.0% of the company shares are owned by institutional investors. The book value of Scpharmaceuticals was at this time reported as 1.03. The company recorded a loss per share of 1.42. Scpharmaceuticals had not issued any dividends in recent years.Check out Scpharmaceuticals Hype Analysis, Scpharmaceuticals Correlation and Scpharmaceuticals Performance. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Scpharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.42) | Revenue Per Share 0.353 | Return On Assets (0.32) | Return On Equity (1.00) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.